
Avatrombopag - Immune thrombocytopenia
You are here : Home > Formulary Search > Avatrombopag - Immune thrombocytopenia
Status 1
- Tablets
Documentation
PAD Profile
Haematology use only - treating primary chronic immune thrombocytopenia as per NICE TA853.
Other Indications
Below are listed other indications that Avatrombopag is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Immune thrombocytopenia.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves the updated ITP pathway.
The Surrey Heartlands Integrated Care System Area Prescribing Committee recommends avatrombopag as a treatment option for the treating primary chronic immune thrombocytopenia in line with NICE TA853
Avatrombopag will be considered RED on the traffic light system. Prescribing will be by hospital specialists only
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.